Author: Members of the Gynecology Cancer Disease Site Group, Gynecology Cancer Disease Site Group
Year: 2017
AGREE II score: Available
Developer organization: Cancer Care Ontario
Type of cancer: Gynecological
Patient population: Adult
Location: Canada-wide, Ontario
This is a clinical practice guideline for adult female patients diagnosed with advanced stage or recurrent endometrial cancer (excluding sarcomas and squamous cell carcinomas) or uterine papillary serous carcinoma. The guideline examines chemotherapeutic and hormonal therapy options for patients with these cancers. Outcomes of interest include improved response rates and survival.
AGREE II - Quality of Reporting Assessment:
Scope and purpose: 83.3%
Applicability: 4.2%
Stakeholder involvement: 27.8%
Editorial independence: 50%
Rigour: 81.2%
Clarity presentation: 80.6%
